Of course, the broader healthcare ecosystem offers a compelling narrative for market participants. As the Covid19 pandemic demonstrated, no matter how advanced we become as a society, a microscopic virus can impose devastation. In order to protect individuals and communities at large, enterprises need a way to address diseases: infectious, chronic, whatever the case may be. Procaps (PROC) Still, for those who want to speculate on undervalued biotech stocks, PROC could be a high-risk, high-reward idea. Right ...